NCT07733440Not yet recruiting
PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria
Clinical Risk Calculator Validation and Implementation to Optimize Prostate Cancer Early Detection in Nigeria
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population. The main questions the validation study aims to answer are: 1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer? 2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer? The main questions the intervention study aims to answer is: Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement? The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 89 (estimated)
- First submitted
- 19 Jul 2026
- Start date
- 1 Mar 2029
- Primary completion date
- 31 Aug 2029
- Lead sponsor
- Ahmadu Bello University
- Diseases
- Prostate cancer
- NCT number
- NCT07733440
What you commit to
- Study type: Interventional
- Planned participants: 89
- From 1 Mar 2029 to the primary completion date, 31 Aug 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Training - Eligible primary care providers (for the training surveys) will be healthcare practitioners at community-level hospitals.
- Supported Risk Assessment
- (i) Eligible key informants will be eligible primary care providers who were trained and implemented the supported risk assessment and the targeted population of patient participants who received the supported risk assessment.
- (ii) Eligible patient participants (for the collection of observation data) will be the target population of adult males 40 - 79 years accessing provider services.
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ahmadu Bello University Teaching Hospital Coordinator of this site? Confirm its status | Zaria | Nigeria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.